TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30778004

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle modification (ILSM)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: ILSM and metformin (ILSM+Met)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Standard care (STD)
Number of subjects: 103
Study: 27734980

Group type: EXPERIMENTAL
Intervention: Steroids + Kabat physical rehabilitation
Number of subjects: 94

Group type: COMPARATOR
Intervention: Steroids alone
Number of subjects: 94
Study: 24518152

Group type: EXPERIMENTAL
Intervention: High-dose grape seed extract (200 mg/d)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Low-dose grape seed extract (100 mg/d)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 23329572

Group type: EXPERIMENTAL
Intervention: Transplantation of autologous mesenchymal stem cells (MSCs) from G-CSF-mobilised peripheral blood
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 21
Study: 20826993

Group type: EXPERIMENTAL
Intervention: Narrow-band UV-B (TL-01) phototherapy, twice-weekly for 3 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral 8-Methoxsalen PUVA, twice-weekly for 3 months
Number of subjects: 60
Study: 18777217

Group type: EXPERIMENTAL
Intervention: Internet-based HIV prevention trial
Number of subjects: 2623
Study: 16698007

Group type: EXPERIMENTAL
Intervention: Aspirin 200 mg/day
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Vitamin C 1 g/day
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Vitamin E 400 mg/day
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study: 14761123

Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 22

Group type: COMPARATOR
Intervention: Non-smokers
Number of subjects: 22
Study: 11168196

Group type: EXPERIMENTAL
Intervention: Autogenous bone grafts (group 1)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Revascularized free flaps (group 2)
Number of subjects: 18
Study: 8739759

Group type: EXPERIMENTAL
Intervention: Palm sweating (PS) measured using hygrometry during short-term memory tasks.
Number of subjects: 6
Study: 8225684

Group type: EXPERIMENTAL
Intervention: Voltaren (V) 100 mg tablet
Number of subjects: 15

Group type: COMPARATOR
Intervention: Diclogesic (D) 100 mg tablet
Number of subjects: 15
Study: 3100463

Group type: EXPERIMENTAL
Intervention: Mequitazine 5 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Astemizole 10 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 29384762

Group type: EXPERIMENTAL
Intervention: Robotic gait training coupled with virtual reality
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (traditional rehabilitative treatment)
Number of subjects: 45
Study: 27356528

Group type: EXPERIMENTAL
Intervention: High-sodium and bicarbonate mineral water (BW, sodium 1 g/L; bicarbonate 2 g/L)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: High-sodium and bicarbonate mineral water (BW) with meal
Number of subjects: 21

Group type: COMPARATOR
Intervention: Low-mineral content control water (CW)
Number of subjects: 21
Study: 24670999

Group type: EXPERIMENTAL
Intervention: Augmented Reality Ophthalmoscopy (ARO)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conventional Ophthalmoscopy
Number of subjects: 37
Study: 23140347

Group type: EXPERIMENTAL
Intervention: ICD therapy (112 patients, 22.5% of total)
Number of subjects: 497

Group type: COMPARATOR
Intervention: Non-ICD therapy (385 patients)
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Overall survival rate
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Incidence of sudden cardiac death
Number of subjects: 497
Study: 20358312

Group type: EXPERIMENTAL
Intervention: Intervention Anganwadi centers
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control Anganwadi centers
Number of subjects: 80
Study: 18660395

Group type: EXPERIMENTAL
Intervention: Surgeon-performed ultrasound
Number of subjects: 800

Group type: COMPARATOR
Intervention: Standard examination without ultrasound
Number of subjects: 800
Study: 15735389

Group type: EXPERIMENTAL
Intervention: Transurethral electrovaporization of the prostate (TUVP)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Standard transurethral prostatectomy (TURP)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: TUVP
Number of subjects: 77

Group type: COMPARATOR
Intervention: TURP
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: TUVP and TURP
Number of subjects: 77
Study: 12358251

Group type: EXPERIMENTAL
Intervention: Tegaserod 2 or 6 mg b.i.d. (n = 1679)
Number of subjects: 2516

Group type: COMPARATOR
Intervention: Placebo (n = 837)
Number of subjects: 2516

Group type: EXPERIMENTAL
Intervention: Tegaserod iv. single doses (0.8 mg to 20 mg)
Number of subjects: 2516

Group type: COMPARATOR
Intervention: Placebo (in healthy subjects)
Number of subjects: 2516
Study: 10356912

Group type: EXPERIMENTAL
Intervention: Admission and discharge values of rosette formation, adhesive and phagocytic ability of neutrophils
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 3-5 weeks of hospital stay
Number of subjects: 48
Study: 7490317

Group type: EXPERIMENTAL
Intervention: Multiple Myeloma
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: MGUS
Number of subjects: 35

Group type: COMPARATOR
Intervention: Healthy Controls
Number of subjects: 35
Study: 1664903

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) subfraction, initial dose of 17 to 95 U/kg and continuous dose of 7 to 20 U/kg/hr
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard heparin
Number of subjects: 10
Study: 7247733

Group type: EXPERIMENTAL
Intervention: Fenofibrate 300mg daily for 1 year
Number of subjects: 0
Study: 31235156

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 55
Study: 27889545

Group type: EXPERIMENTAL
Intervention: CO2 insufflation
Number of subjects: 215

Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 215
Study: 26359512

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg (high-dose statin therapy)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pravastatin 20 mg (low-dose statin therapy)
Number of subjects: 60
Study: 23401294

Group type: EXPERIMENTAL
Intervention: Posture-training support
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Spinomed orthosis
Number of subjects: 18

Group type: COMPARATOR
Intervention: Spinomed orthosis and posture-training support
Number of subjects: 18
Study: 20951997

Group type: EXPERIMENTAL
Intervention: Magnetic Seizure Therapy (MST)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Electroconvulsive Therapy (ECT)
Number of subjects: 20
Study: 18408861

Group type: EXPERIMENTAL
Intervention: Phonological remediation program (Gonzalez & Rosquete, 2002)
Number of subjects: 24
Study: 16549997

Group type: EXPERIMENTAL
Intervention: Gefitinib (250 mg/day)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m2 every 3 weeks)
Number of subjects: 141
Study: 14739683

Group type: EXPERIMENTAL
Intervention: Agalsidase alfa enzyme replacement therapy
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 10801172

Group type: EXPERIMENTAL
Intervention: Radiotherapy (20 Gy in ten fractions)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham-irradiation (ten fractions of 0 Gy)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham-irradiation
Number of subjects: 30
Study: 8839837

Group type: EXPERIMENTAL
Intervention: Low-dose sIL-1RI
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High-dose sIL-1RI
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: sIL-1RI (both doses)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 1626735

Group type: EXPERIMENTAL
Intervention: Anistreplase (30 units intravenously over five minutes)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Streptokinase (750,000 units intravenously over thirty to sixty minutes)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Anistreplase
Number of subjects: 110

Group type: COMPARATOR
Intervention: Streptokinase
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 110
Study: 6385681

Group type: EXPERIMENTAL
Intervention: Diltiazem, 360 mg/day
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 31786030

Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg/kg
Number of subjects: 63

Group type: COMPARATOR
Intervention: Esketamine 0.25 mg/kg
Number of subjects: 63
Study: 29551030

Group type: EXPERIMENTAL
Intervention: Eltrombopag (25 mg/d)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 27101291

Group type: EXPERIMENTAL
Intervention: Aerobic exercise followed by resistance exercise (AE + RE)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Resistance exercise only (RE)
Number of subjects: 10
Study: 26200539

Group type: EXPERIMENTAL
Intervention: Transperitoneal (TP) approach
Number of subjects: 62

Group type: COMPARATOR
Intervention: Extraperitoneal (EP) approach
Number of subjects: 62
Study: 23857041

Group type: EXPERIMENTAL
Intervention: Automatic titration guided by the BIS (dual-loop group)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Manual target-controlled infusion of propofol and remifentanil (manual TCI group)
Number of subjects: 67
Study: 20956635

Group type: COMPARATOR
Intervention: Fixed starting dose
Number of subjects: 210

Group type: COMPARATOR
Intervention: 70% of individual MED
Number of subjects: 210

Group type: COMPARATOR
Intervention: 50% of individual MED
Number of subjects: 210
Study: 18720268

Group type: EXPERIMENTAL
Intervention: Heroin dependence
Number of subjects: 16
Study: 17026488

Group type: EXPERIMENTAL
Intervention: RSG/MET fixed-dose combination therapy (AVANDAMET) 4 mg/1000 mg up-titrated to 8 mg/2000 mg
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: RSG/MET fixed-dose combination therapy (AVANDAMET)
Number of subjects: 190
Study: 15058690

Group type: EXPERIMENTAL
Intervention: Category learning task
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5-4 categories
Number of subjects: 0
Study: 10722500

Group type: EXPERIMENTAL
Intervention: Amprenavir, 1,200 mg twice daily over 4 days (seven doses)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Clarithromycin, 500 mg twice daily over 4 days (seven doses)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Combination of amprenavir and clarithromycin over 4 days (seven doses of each drug)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 14
Study: 8737758

Group type: EXPERIMENTAL
Intervention: Doxapram
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 1444526

Group type: EXPERIMENTAL
Intervention: 0.3 g/kg IVIG at two week intervals
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 3932106

Group type: EXPERIMENTAL
Intervention: Dexchlorpheniramine maleate 6 mg b.i.d.
Number of subjects: 174

Group type: COMPARATOR
Intervention: Terfenadine 60 mg b.i.d.
Number of subjects: 174
Study: 31386926

Group type: EXPERIMENTAL
Intervention: Labin electronic dynamometer
Number of subjects: 34

Group type: COMPARATOR
Intervention: Jamar hydraulic hand dynamometer
Number of subjects: 34
Study: 29317111

Group type: EXPERIMENTAL
Intervention: Tiotropium Respimat® 5 and 2.5μg
Number of subjects: 17116
Study: 25965388

Group type: EXPERIMENTAL
Intervention: 6-week spiritual reminiscence intervention
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 103
Study: 25139882

Group type: EXPERIMENTAL
Intervention: Glucagon 25 μg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Glucagon 75 μg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Glucagon 125 μg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Glucagon 175 μg
Number of subjects: 11

Group type: COMPARATOR
Intervention: High insulin levels (0.05 units/kg/h)
Number of subjects: 11
Study: 22935145

Group type: EXPERIMENTAL
Intervention: Perceived severity of nonmelanoma skin cancer
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Perceived severity of melanoma
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Perceived susceptibility to skin cancer
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: BMI-for-age
Number of subjects: 999
Study: 20706110

Group type: EXPERIMENTAL
Intervention: Intermittent CPT (thrice weekly)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Daily CPT
Number of subjects: 324
Study: 19102975

Group type: EXPERIMENTAL
Intervention: TMMU formula for fluid resuscitation
Number of subjects: 71
Study: 16798862

Group type: EXPERIMENTAL
Intervention: Atraumatic Restorative Treatment (ART) with high-viscosity glass ionomer
Number of subjects: 681

Group type: COMPARATOR
Intervention: Traditional approach (TA) with amalgam
Number of subjects: 681
Study: 14714836

Group type: EXPERIMENTAL
Intervention: Aesthetic Plus
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: DT
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: FRC Postec
Number of subjects: 225
Study: 10974963

Group type: EXPERIMENTAL
Intervention: Active medication review by a pharmacist
Number of subjects: 330
Study: 8788406

Group type: EXPERIMENTAL
Intervention: Contingency contracting with a partner
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Contingency contracting alone
Number of subjects: 84

Group type: COMPARATOR
Intervention: No contingency contracting
Number of subjects: 84
Study: 1323576

Group type: EXPERIMENTAL
Intervention: 10(6) TCID50 of CP18 PIV‐3 vaccine administered intranasally to seropositive older children (41 to 124 months)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: 10(5) TCID50 of CP18 PIV‐3 vaccine administered intranasally to seropositive young children
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: 10(6) TCID50 of CP18 PIV‐3 vaccine administered intranasally to seropositive young children
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: 10(6) TCID50 of CP18 PIV‐3 vaccine administered intranasally to seronegative young children
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: CP18 PIV‐3 vaccine in seronegative young children
Number of subjects: 95

Group type: COMPARATOR
Intervention: Vaccine virus spread from a vaccinated child to a sibling control
Number of subjects: 95
Study: 6829580

Group type: EXPERIMENTAL
Intervention: ROA format
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: R format
Number of subjects: 271

Group type: COMPARATOR
Intervention: Control group (no written information)
Number of subjects: 271
Study: 31168922

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (5-6 weekly aerobic and combined aerobic and strength training sessions, 30-60 minutes, individual dietary plans aiming for BMI ≤25 kg/m2)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard care (standardized, blinded, target-driven medical therapy during the initial 12 months)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (considering lost to follow-up as relapsed)
Number of subjects: 98
Study: 30170399

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine fumigation 'Bone-healing Powder'
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 0
Study: 27210235

Group type: EXPERIMENTAL
Intervention: BoNT/A injection (100 units)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (education only)
Number of subjects: 46
Study: 25219601

Group type: EXPERIMENTAL
Intervention: Baicalein (100-2800 mg)
Number of subjects: 72
Study: 22727067

Group type: EXPERIMENTAL
Intervention: Test formulation of nateglinide (60 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Reference formulation of nateglinide (60 mg)
Number of subjects: 20
Study: 19655157

Group type: EXPERIMENTAL
Intervention: Ethinylestradiol + cyproterone acetate (2 mg, EE/CA)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ethinylestradiol + cyproterone acetate (2 mg, EE/CA) with spironolactone (Sp)
Number of subjects: 56
Study: 17585086

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (1200 mg/d for 10 days, tapered thereafter)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 16040590

Group type: EXPERIMENTAL
Intervention: Therapeutic exercise program (12-week duration)
Number of subjects: 100
Study: 12110042

Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (test)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cellulose starch (placebo)
Number of subjects: 60
Study: 10549990

Group type: EXPERIMENTAL
Intervention: GHB (50 mg/kg body weight for 10 days)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Diazepam (0.5-0.75 mg/kg body weight for 6 days, tapering the dose 25% daily until day 10)
Number of subjects: 60
Study: 7634674

Group type: EXPERIMENTAL
Intervention: Standard treatment for avulsion fractures (no immobilization)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Standard treatment for shaft/neck fractures (plaster casts with weight bearing as tolerated)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Standard treatment for true Jones' fractures (8 weeks nonweight bearing followed by weight bearing as tolerated in a cast)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Surgical fixation for conservative treatment failure
Number of subjects: 100
Study: 2179764

Group type: EXPERIMENTAL
Intervention: 5 X 10(6) IU IFN subcutaneously daily for 6 months
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 6781372

Group type: EXPERIMENTAL
Intervention: Standardized allergen provocations
Number of subjects: 18

Group type: COMPARATOR
Intervention: Negative provocations
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Pretreatment with disodium cromoglycate and ICI 74.917
Number of subjects: 18
Study: 31989758

Group type: EXPERIMENTAL
Intervention: Standards for Co‐production of Education (Mental Health Nursing) (SCo‐PE [MHN])
Number of subjects: 50
Study: 30972062

Group type: EXPERIMENTAL
Intervention: Myeloid-derived cells targeted treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preclinical studies and clinical trials
Number of subjects: 0
Study: 27677368

Group type: EXPERIMENTAL
Intervention: Corn oil (CO)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Extra-virgin olive oil (EVOO)
Number of subjects: 54
Study: 26445823

Group type: EXPERIMENTAL
Intervention: Autologous fibrin glue
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Commercial porcine fibrin sealants
Number of subjects: 171

Group type: COMPARATOR
Intervention: Drainage cessation
Number of subjects: 171
Study: 23356823

Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus (4 × 10^9 colony‐forming units/day) for 5 days
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 21261786

Group type: COMPARATOR
Intervention: Zinc
Number of subjects: 480

Group type: COMPARATOR
Intervention: S. boulardii plus zinc
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Zinc plus S. boulardii
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: S. boulardii plus lactose-free formula
Number of subjects: 480

Group type: COMPARATOR
Intervention: Lactose-free formula
Number of subjects: 480

Group type: COMPARATOR
Intervention: S. boulardii
Number of subjects: 480

Group type: COMPARATOR
Intervention: Oral and/or parenteral rehydration solutions
Number of subjects: 480
Study: 19479626

Group type: EXPERIMENTAL
Intervention: Quercetin (250 mg)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Quercetin
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Quercetin and Placebo
Number of subjects: 63
Study: 17901387

Group type: EXPERIMENTAL
Intervention: Tinzaparin
Number of subjects: 1484

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 1484
Study: 15319599

Group type: EXPERIMENTAL
Intervention: 99mTc nanocolloid (99mTc‐NC) (10 MBq) and 111In‐HIG (2 MBq) as a mixture (0.2 ml)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 99mTc‐HIG (10 MBq) and 111In‐HIG (2 MBq) as a mixture (0.2 ml)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 99mTc‐HIG (10 MBq) and 111In‐HIG (2 MBq) separately (both 0.2 ml)
Number of subjects: 10
Study: 11552184

Group type: EXPERIMENTAL
Intervention: Tizanidine
Number of subjects: 17
Study: 9611088

Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (TD) challenge with 43 g of an amino acid mixture containing five large neutral amino acids
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group received the same amino acid mixture with 2.3 g tryptophan added
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Baseline cortisol levels in responders to TD
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Correlation of platelet serotonin-receptor function and plasma prolactin levels
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Baseline data correlation between rated mood state and plasma cortisol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Baseline data correlation between rated mood state and plasma tryptophan concentration
Number of subjects: 20
Study: 7803993

Group type: EXPERIMENTAL
Intervention: Intralipid 20% (long‐chain triglycerides)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Lipofundin MCT/LCT 20% (10% each of long‐ and medium‐chain triglycerides)
Number of subjects: 23
Study: 3052916

Group type: EXPERIMENTAL
Intervention: Right Heart Cooling (RHC)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standard Protection (SC)
Number of subjects: 78
Study: 30999382

Group type: EXPERIMENTAL
Intervention: Combined massage therapy and phototherapy
Number of subjects: 83

Group type: COMPARATOR
Intervention: Phototherapy (Control)
Number of subjects: 83
Study: 28343774

Group type: EXPERIMENTAL
Intervention: 60μg recombinant hepatitis B vaccine
Number of subjects: 196

Group type: COMPARATOR
Intervention: 20μg recombinant hepatitis B vaccine
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Both 20μg and 60μg vaccine groups
Number of subjects: 196
Study: 26521577

Group type: EXPERIMENTAL
Intervention: Matrix needling technique combined with rehabilitation training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional rehabilitation therapy (intermittent catheterization and bladder function training)
Number of subjects: 60
Study: 23578949

Group type: COMPARATOR
Intervention: Standard Intrauterine Insemination (SIUI)
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Fallopian Tube Sperm Perfusion (FSP)
Number of subjects: 417